triiodothyronine has been researched along with Glioblastoma in 3 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
Excerpt | Relevance | Reference |
---|---|---|
"Regorafenib demonstrated encouraging results in recurrent glioblastoma patients." | 8.31 | Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study. ( Bruno, F; Caccese, M; Cavallin, F; Cerretti, G; Chioffi, F; Coppola, M; Della Puppa, A; Denaro, L; Desideri, I; Fiorentino, A; Livi, L; Lombardi, G; Maccari, M; Padovan, M; Pittaro, A; Rudà, R, 2023) |
"Regorafenib demonstrated encouraging results in recurrent glioblastoma patients." | 4.31 | Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study. ( Bruno, F; Caccese, M; Cavallin, F; Cerretti, G; Chioffi, F; Coppola, M; Della Puppa, A; Denaro, L; Desideri, I; Fiorentino, A; Livi, L; Lombardi, G; Maccari, M; Padovan, M; Pittaro, A; Rudà, R, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Caccese, M | 1 |
Desideri, I | 1 |
Padovan, M | 1 |
Bruno, F | 1 |
Cerretti, G | 1 |
Fiorentino, A | 1 |
Denaro, L | 1 |
Chioffi, F | 1 |
Della Puppa, A | 1 |
Maccari, M | 1 |
Cavallin, F | 1 |
Coppola, M | 1 |
Pittaro, A | 1 |
Rudà, R | 1 |
Livi, L | 1 |
Lombardi, G | 1 |
Pinna, G | 1 |
Meinhold, H | 1 |
Hiedra, L | 1 |
Thoma, R | 1 |
Hoell, T | 1 |
Gräf, KJ | 1 |
Stoltenburg-Didinger, G | 1 |
Eravci, M | 1 |
Prengel, H | 1 |
Brödel, O | 1 |
Finke, R | 1 |
Baumgartner, A | 1 |
Morales, P | 1 |
Bosch, A | 1 |
Lopez, R | 1 |
Nery, C | 1 |
Borras, F | 1 |
Rosa, M | 1 |
3 other studies available for triiodothyronine and Glioblastoma
Article | Year |
---|---|
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
Topics: Glioblastoma; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Function Tests; Thy | 2023 |
Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors.
Topics: Astrocytoma; Brain Injuries; Brain Neoplasms; Craniocerebral Trauma; Diiodothyronines; Glioblastoma; | 1997 |
Radiotherapy and L-triiodothyronine in the treatment of high-grade astrocytoma.
Topics: Adult; Aged; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Radiation T | 1988 |